LIPID METABOLISM DISORDERS AND CARDIOVASCULAR DISEASES

Authors

  • Qo‘shshayeva Mahliyo Bobirjonovna 3rd-year Student, Faculty of Medicine Tashkent State Medical University Tashkent, Uzbekistan

Keywords:

lipid metabolism, dyslipidemia, cholesterol, triglycerides, lipoproteins, atherosclerosis, cardiovascular disease, LDL cholesterol, HDL cholesterol.

Abstract

Lipid metabolism is a complex biochemical process responsible for the synthesis, transport, utilization, and storage of lipids in the human body. Disturbances in this system can lead to abnormal concentrations of cholesterol, triglycerides, and lipoproteins in the circulation and may substantially increase the risk of cardiovascular disease. Dyslipidemia, particularly elevated low-density lipoprotein cholesterol and triglyceride levels, plays an important role in the development and progression of atherosclerosis. Excessive accumulation of atherogenic lipoproteins within the arterial wall initiates inflammatory and structural changes that can eventually result in coronary artery disease, myocardial infarction, ischemic stroke, and other cardiovascular complications. The development of lipid abnormalities is influenced by genetic predisposition, dietary patterns, obesity, physical inactivity, metabolic disorders, and certain medications. This article examines the biochemical characteristics of lipid metabolism disorders, their relationship with cardiovascular pathology, major risk factors, and current approaches to prevention and management. Particular attention is given to the role of lifestyle modification and lipid-lowering therapy in reducing cardiovascular risk. Understanding the metabolic mechanisms underlying dyslipidemia is important for early identification of high-risk individuals and for developing effective strategies to prevent cardiovascular complications.

References

Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524–533.

Borén J, Chapman MJ, Krauss RM, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights. European Heart Journal. 2020;41(24):2313–2330.

Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. European Heart Journal. 2017;38(32):2459–2472.

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC guideline on the management of blood cholesterol. Circulation. 2019;139:e1082–e1143.

Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal. 2020;41(1):111–188.

Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors. Journal of the American College of Cardiology. 2020;76(25):2982–3021.

Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nature Reviews Disease Primers. 2019;5:56.

Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Primary Care. 2013;40(1):195–211.

Downloads

Published

2026-08-23

How to Cite

Qo‘shshayeva Mahliyo Bobirjonovna. (2026). LIPID METABOLISM DISORDERS AND CARDIOVASCULAR DISEASES. IQRO , 23(01), 394–398. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/8939